###begin article-title 0
Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia
###end article-title 0
###begin p 1
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org.
###end p 1
###begin title 2
Aims
###end title 2
###begin p 3
###xml 142 144 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Sepsis-associated cardiac dysfunction represents an intrinsic impairment of cardiomyocyte function due in part to a decrease in myofilament Ca2+ sensitivity associated with a sustained increase in cardiac troponin I (cTnI) phosphorylation at Ser23/24. Dephosphorylation of cTnI is under regulatory control. Thus, muscarinic and adenosine A1-receptor agonists antagonize beta-adrenergic stimulation via activation of protein phosphatase 2A (PP2A). The aim of this study was to determine whether modulation of PP2A and thus cTnI phosphorylation could improve sepsis-induced contractile dysfunction.
###end p 3
###begin title 4
Methods and results
###end title 4
###begin p 5
###xml 408 410 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 461 462 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 621 623 621 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Cardiomyocytes were isolated from control or septic mice 16-18 h after an injection of vehicle or lipopolysaccharide (LPS; 9 mg/kg ip) respectively. Protein expression and phosphatase activity were determined in homogenates of control and septic hearts. Our data showed that LPS significantly increased cTnI phosphorylation at Ser23/24 in cardiomyocytes and reduced contraction amplitude without affecting Ca2+-transients. Treatment of cardiomyocytes with the A1 agonist cyclopentyladenosine (CPA) or the protein kinase A inhibitor H89 significantly attenuated the LPS-induced contractile dysfunction without effect on Ca2+-transients. Co-treatment with CPA and H89 completely reversed the contractile dysfunction. Increased cTnI phosphorylation in septic hearts was associated with a significant reduction in the protein expression of both the catalytic and regulatory subunits (B56alpha) of PP2A and a decrease in PP2A activity. CPA treatment of septic hearts increased PP2A activity. An increase in the protein expression of demethylated PP2A and a decrease in the PP2A-methyltransferase (PPMT; the methyltransferase that catalyses this reaction) were also observed.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
These data support the hypothesis that sustained cTnI phosphorylation underlies the contractile dysfunction seen in sepsis.
###end p 7
###begin title 8
KEYWORDS
###end title 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C1">1</xref>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C1">1</xref></sup>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C2">2</xref>
###xml 525 526 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C2">2</xref></sup>
###xml 813 814 813 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C3">3</xref>
###xml 813 814 813 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C3">3</xref></sup>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
Endotoxemia and sepsis involve a major inflammatory response, frequently associated with hypotension, vascular hyporeactivity, cardiac depression, and multiple organ failure. Despite prompt treatment with antibiotics and supportive care, the mortality of septic patients is still high, with the number of deaths from sepsis equalling the number of deaths from myocardial infarction in the USA.1 Myocardial dysfunction is a common complication in patients with severe sepsis and results in a significantly increased mortality.2 Such dysfunction is characterized by depressed ejection fraction and stroke work and increased end-diastolic volumes. Since the reduction in contractility is independent of alterations in cardiac load or heart rate, it largely represents an intrinsic depression of contractile function.3
###end p 10
###begin p 11
###xml 270 272 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C4">4</xref>
###xml 286 287 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C4">4</xref></sup>
###xml 385 387 385 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C5">5</xref>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C5">5</xref></sup>
###xml 1035 1036 1035 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C5">5</xref>
###xml 1035 1036 1035 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C5">5</xref></sup>
###xml 1285 1286 1285 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C6">6</xref>
###xml 1285 1286 1285 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C6">6</xref></sup>
###xml 1522 1523 1522 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 1522 1523 1522 1523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref></sup>
###xml 1550 1557 1550 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1846 1847 1846 1847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C8">8</xref>
###xml 1848 1849 1848 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C9">9</xref>
###xml 1846 1849 1846 1849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C8">8</xref>,<xref ref-type="bibr" rid="CVP037C9">9</xref></sup>
###xml 1946 1947 1946 1947 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1992 1993 1992 1993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 1994 1996 1994 1996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C10">10</xref>
###xml 1997 1999 1997 1999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C11">11</xref>
###xml 1992 1999 1992 1999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref>,<xref ref-type="bibr" rid="CVP037C10">10</xref>,<xref ref-type="bibr" rid="CVP037C11">11</xref></sup>
###xml 2004 2005 2001 2002 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2028 2030 2025 2027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C12">12</xref>
###xml 2028 2030 2025 2027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C12">12</xref></sup>
###xml 2036 2038 2033 2035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C13">13</xref>
###xml 2036 2038 2033 2035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C13">13</xref></sup>
###xml 2045 2047 2042 2044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C14">14</xref>
###xml 2045 2047 2042 2044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C14">14</xref></sup>
###xml 2054 2056 2051 2053 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 2057 2059 2054 2056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C15">15</xref>
###xml 2057 2059 2054 2056 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C15">15</xref></sup>
###xml 2187 2188 2184 2185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 2189 2191 2186 2188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C10">10</xref>
###xml 2187 2191 2184 2188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref>,<xref ref-type="bibr" rid="CVP037C10">10</xref></sup>
###xml 2267 2268 2264 2265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 2267 2268 2264 2265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref></sup>
###xml 98 101 <span type="species:ncbi:10116">rat</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
Previous data from our laboratory have demonstrated that 16-18 h after LPS injection, endotoxemic rat hearts show increased cardiac troponin I (cTnI) phosphorylation at Ser23/24, residues that mediate protein kinase A (PKA)-dependent reduction of myofilament calcium (Ca2+) sensitivity.4 No reduction in the calcium transient was observed, suggesting that a reduction in myofilament Ca2+ sensitivity largely underlies the contractile dysfunction. More recent studies have confirmed the functional importance of increased cTnI phosphorylation in endotoxemia by demonstrating that mice with cardiac-specific replacement of cTnI with slow skeletal TnI (ssTnI), which lacks the PKA phosphorylation sites in the N-terminal, are significantly protected against LPS-induced cardiac dysfunction.5 Moreover, this protection was also observed in Triton-skinned cardiomyocytes. No degradation of cTnI or TnT in LPS-treated animals was observed nor were differences in the phosphorylation of other myofilament proteins between the groups detected.5 Such sustained increase in cTnI phosphorylation could result from either sustained kinase activation or inhibition of dephosphorylation pathways. Although the pathways regulating cTnI phosphorylation at the PKA sites are relatively well understood,6 the mechanism(s) regulating the dephosphorylation pathways remain unclear. A major dephosphorylating enzyme is protein phosphatase 2A (PP2A), a multimeric serine/threonine phosphatase which dephosphorylates both cTnI and phospholamban.7 PP2A predominately exists in vivo as a heterodimer of the catalytic subunit C constitutively bound to the scaffolding subunit A. These can then further complex with one of several regulatory B subunits. The B subunits contain all the targeting information that directs the heterotrimer to distinct intracellular locations.8,9 A number of agonists and compounds have been reported to activate PP2A including the adenosine A1-receptor agonist cyclopentyladenosine (CPA),7,10,11 beta2-adrenoceptor agonists,12 cAMP,13 PAK 1,14 and Ca2+.15 CPA has been shown by a number of authors to induce the translocation of the C subunit of PP2A from the cytosol to the membrane7,10 and decrease phosphorylation of a number of protein targets including cTnI.7 Thus, the aim of this study was to investigate whether changes in the regulation of PP2A underlie the sustained phosphorylation of cTnI in myocytes from endotoxemic hearts.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Animal models
###end title 13
###begin p 14
###xml 303 319 303 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 303 319 <span type="species:ncbi:562">Escherichia coli</span>
All experiments were performed in accordance with UK Home Office regulations and the investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23 revised 1996). C57/BL6 mice were injected with 7-9 mg/kg ip Escherichia coli bacterial lipopolysaccharide (LPS; serotype 0.11: B4, Sigma Aldrich, UK) or an equivalent volume of saline and sacrificed 16-18 h later.
###end p 14
###begin title 15
Isolated myocytes
###end title 15
###begin p 16
###xml 129 148 129 148 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.afcs.org">http://www.afcs.org</uri>
###xml 148 150 148 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 221 223 221 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 410 412 410 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 472 474 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C16">16</xref>
###xml 472 474 468 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C16">16</xref></sup>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Ventricular myocytes were isolated from C57Bl/6 mice following a modified version of the AfCS procedure protocol (# PP00000125) (http://www.afcs.org). The digestion protocol typically yielded 60-70% rod-shaped, viable, Ca2+ tolerant myocytes from both control and septic hearts. The cells were stored in the final buffer at room temperature and used within 5-6 h. Some cells were loaded with the fluorescent Ca2+ indicator Indo-1 AM (2 micromol/L) as described previously.16
###end p 16
###begin p 17
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C5">5</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C17">17</xref>
###xml 240 244 240 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C5">5</xref>,<xref ref-type="bibr" rid="CVP037C17">17</xref></sup>
Single myocyte contractility and indo-1 AM fluorescence were studied on the stage of an inverted fluorescence microscope (Nikon Diaphot) coupled to a dual emission spectrophotometer (Cairn Research, Faversham, Kent) as described previously.5,17
###end p 17
###begin title 18
Ventricular homogenate preparation
###end title 18
###begin p 19
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 177 178 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 845 846 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Control and septic hearts were retrogradely perfused with Krebs-Henseleit buffer (KHB) (CaCl2 1.25 mmol/L, glucose 10 mmol/L, and Na-pyruvate 5.0 mmol/L; bubbled with 95%O2:5%CO2 at 37degreesC) at a constant coronary perfusion pressure of 75 mmHg. Hearts were paced at 588 bpm. In some hearts, once the hearts were stable the perfusate was switched to KHB +/- CPA (1 micromol/L) for 10 min, following which ventricles were snap-frozen in liquid nitrogen. All subsequent procedures were carried out at 4degreesC. Ventricles were thawed in buffer containing 250 mmol/L sucrose, 2 mmol/L EDTA, 2 mmol/L EGTA, 20 mmol/L HEPES, protease inhibitor cocktail, 1 mM sodium ortho-vanadate, and 1 mM NaF, pH 7.4, and homogenized (10% w/v) by a hand-held ground glass grinder and then sonicated three times in 10 s bursts. Samples were centrifuged (100 000 g for 1 h) to separate cytosolic and particulate fractions.
###end p 19
###begin title 20
Gel electrophoresis and immunoblot analysis
###end title 20
###begin p 21
Samples were re-suspended in Laemlli buffer with reducing agents and the protein levels were determined by RC-DC Bio-Rad protein assay with BSA as standard. For western analysis, 30 microg of soluble extract protein was used per lane. Samples were subjected to electrophoresis (10% gel) and transferred to nitrocellulose. After blocking (3%BSA/TBST 1 h, RT), the membranes were probed using a range of primary antibodies against PP2A B56alpha subunit (BD Transduction Laboratories), PP2A-C subunit, PP2A-A subunit, PP2A demethylated, P-TnI Ser23/24, total cTnI (Cell Signalling Technologies), anti-PP2A-methyltransferase/PPMT1, clone 4A4, anti-Rac-1 clone 23A8 (Upstate Cell Signalling Solutions), and HRP-conjugated secondary antibodies. The bound antibodies were visualized by chemiluminescence detection and protein levels were quantified by scanning densitometry using TotalLab(c) software.
###end p 21
###begin title 22
Real-time reverse transcriptase-polymerase chain reaction
###end title 22
###begin p 23
Total RNA was purified from heart homogenate using an SV RNA extraction kit (Promega, UK) and reverse transcribed using MLV-RT (Promega). Expression of the B56alpha subunit of PP2A was analysed by real-time RT-PCR using fluorescent SYBR Green technology on a Prism 7000 HT system (Applied Biosystems, USA), and with beta-actin mRNA used for normalization. To obtain quantitative results, standard curves were constructed from cDNA standards for the B56alpha gene. Results were then normalized by expression as a molar/molar ratio to beta-actin. The following primers were used (5'-3'): beta-actin forward CGTGAAAAGATGACCCAGATCA, reverse TGGTACGACCAGAGGCATACAG; B56alpha forward TACAGTTGGTGTATGAATTCTTCTTGAG, reverse GAGCTGTTGGACAAACTTCTGATC.
###end p 23
###begin title 24
Protein phosphatase 2A activity assay
###end title 24
###begin p 25
###xml 261 262 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 772 773 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 797 798 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 78 87 <span type="species:ncbi:64457">Malachite</span>
###xml 1041 1050 <span type="species:ncbi:64457">Malachite</span>
Protein phosphatase 2A activity was measured in whole heart homogenate with a Malachite Green Phosphatase assay kit (Millipore). Samples were homogenized with a Dounce homogenizer in ice cold buffer containing 250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgSO4, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 0.1 mg/mL PMSF, 45 microg/microL aprotinin, and 1 mM sodium vanadate. Samples were then sonicated three times in 10 s bursts. The baseline phosphatase activity was measured and subtracted from all samples. Detergent was not included in the assay buffer as it was found that detergent reduced PP2A activity by approximately40% (data not shown). Samples were diluted to 25 microg of protein with phosphate-free buffer containing 0.1 M NaOH, 60 mM beta-mercaptoethanol, 1 mM MgCl2, 1 mM EGTA, 0.1 mM MnCl2 1 mM DTT, 10% glycerol, and 0.1 mg/mL BSA, pH 7.4, and added to the wells of a 96-well plate. After addition of 5 microL of the phosphopeptide, samples were incubated for 30 min at room temperature. The reaction was terminated by addition of Malachite green solution. The colour was allowed to develop for 15 min at room temperature and the free phosphate levels were determined by measuring absorbance at 612 nm. The proportion of signal that could be inhibited by okadaic acid (10 nM) was considered as the PP2A activity, which was expressed as a percentage of total phosphatase activity.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 146 147 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 202 210 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 248 249 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All data are shown as mean +/- SEM of at least three different experiments. Significance was determined either with an unpaired two-way Student's t-test or with one-way ANOVA with Student-Newman-Keul's post hoc analysis (Prism 4.0, GraphPad, USA). P < 0.05 was considered significant.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Depression of cardiac function in septic myocytes is reversed by the combination of an A1 agonist and a protein kinase A inhibitor
###end title 29
###begin p 30
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C5">5</xref>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C5">5</xref></sup>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 109 112 109 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F1">1</xref>
###xml 171 180 171 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures&#160;<xref ref-type="fig" rid="CVP037F1">1</xref></italic>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 185 187 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="CVP037F2">2</xref>A</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F1">1</xref>
###xml 325 335 325 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures&#160;<xref ref-type="fig" rid="CVP037F1">1</xref>B</italic>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 340 342 340 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="CVP037F2">2</xref>E</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 589 590 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 590 593 582 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 602 603 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 595 604 587 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F2">2</xref>A</italic>
###xml 609 610 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 763 764 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 780 781 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 773 782 759 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F2">2</xref>A</italic>
###xml 810 811 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 811 814 797 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 853 854 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 846 855 832 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F2">2</xref>B</italic>
###xml 1028 1029 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1087 1088 1071 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 1080 1089 1064 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F2">2</xref>A</italic>
###xml 1091 1092 1075 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1098 1099 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1271 1273 1255 1257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1292 1293 1276 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 1285 1294 1269 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F2">2</xref>E</italic>
###xml 1295 1296 1279 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1353 1354 1337 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 1354 1357 1338 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1421 1422 1397 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1438 1439 1414 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 1431 1440 1407 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F2">2</xref>B</italic>
In line with our previous studies,5 unloaded sarcomere shortening (SS) and the maximum shortening velocity (Vmax) were significantly reduced in septic myocytes (P < 0.05; Figures 1 and 2A and B) 16-18 h following LPS administration. This reduction in contractility was not associated with any changes in the Ca2+-transients (Figures 1B and 2E-G), suggesting that a decrease in myofilament Ca2+ sensitivity underlies the contractile dysfunction induced by LPS. Treatment of control cells with CPA (1 micromol/L) or H89 (1 micromol/L) (individually or in combination) had no effect on SS or Vmax (Figure 2A and B). In contrast, in septic cells, SS was significantly improved with either CPA or H89 (from 3.9 +/- 0.3% to 5.4 +/- 0.3% and 5.2 +/- 0.2%, respectively; P < 0.05; Figure 2A) although the reduction in Vmax was not significantly altered (Figure 2B). Furthermore, when septic cells were treated with both CPA and H89 together there was a further improvement in SS (over and above either treatment alone) to 7.0 +/- 0.5% (P < 0.05 vs. control septic or septic + CPA or H89; Figure 2A, C, and D). Thus, the combination restored contraction amplitude such that it was not significantly different from that of control myocytes. None of these treatments affected the Ca2+ transient (Figure 2E-G). The combination of CPA and H89 significantly improved Vmax to control levels (from -2.2 +/- 0.1 to -4.3 +/- 0.3 microm/s; P < 0.01; Figure 2B).
###end p 30
###begin p 31
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 190 192 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
(A) Representative trace of sarcomere shortening from representative myocytes from saline (black line)- or lipopolysaccharide (LPS; grey line)-treated hearts. (B) Associated intracellular Ca2+-transients (Indo-1 410/480 ratio) of myocytes from saline (black trace)- or LPS (grey trace)-treated hearts.
###end p 31
###begin p 32
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 209 210 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 246 247 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 261 262 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 293 294 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 294 297 286 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 311 312 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 317 318 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 466 467 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 484 486 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 527 529 515 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 540 542 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 574 575 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 585 586 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
(A) Averaged contraction data from saline- or lipopolysaccharide-treated mouse myocytes in the presence of cyclopentyladenosine (CPA) (1 micromol/L), H89 (1 micromol/L), or co-treatment with both CPA and H89 (n = 80-100 cells from three hearts; *P < 0.01) and (B) maximum shortening velocity (Vmax, microm/s). (C and D) Representative traces for single cells showing the effect of co-treatment with both CPA and H89 for 10 min on a control (C) and septic cell (D). (E) Amplitude of Ca2+-transients (Indo-1 410/480 ratio) and RT50 (ms) of Ca2+-transients in the presence of (F) CPA or (G) H89. Bars represent mean +/- SE of the mean.
###end p 32
###begin title 33
Cyclopentyladenosine reverses increased cardiac troponin I phosphorylation associated with sepsis
###end title 33
###begin p 34
###xml 30 31 30 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C4">4</xref>
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C4">4</xref></sup>
###xml 192 193 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 209 210 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F3">3</xref>
###xml 202 211 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F3">3</xref>A</italic>
In line with previous studies,4 the depression in contractile function in septic myocytes was associated with a significant (approximately2-fold) increase in cTnI phosphorylation at Ser23/24 (P < 0.05; Figure 3A). The increase in phosphorylation in septic myocytes was equivalent to that achieved in control myocytes with isoprenaline treatment. However, in septic myocytes, isoprenaline was unable to elicit any additional phosphorylation at Ser23/24 suggesting that these sites may be already maximally phosphorylated.
###end p 34
###begin p 35
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 251 252 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 269 270 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 281 282 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 442 443 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 460 461 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Representative blot of cardiac troponin I (cTnI) phosphorylation at Ser23/24 with beta-actin loading control and quantification of Ser23/24 phosphorylation in control and septic myocytes in the presence and absence of 10 nmol/L isoprenaline (ISO; n = 3 hearts/gp, *P < 0.05). (B) Representative blot and quantification of cTnI phosphorylation at Ser23/24 in septic hearts in the presence and absence of 1 micromol/L cyclopentyladenosine (n = 3 hearts/gp, *P < 0.001). Band intensities are normalized to beta-actin as a loading control.
###end p 35
###begin p 36
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F3">3</xref>
###xml 233 242 233 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F3">3</xref>B</italic>
In line with the hypothesis that increased cTnI phosphorylation is a fundamental mechanism underlying the contractile defect in septic myocytes, CPA treatment completely reversed the LPS-induced increase in Ser23/24 phosphorylation (Figure 3B).
###end p 36
###begin title 37
Protein phosphatase 2A-C expression is significantly decreased in septic hearts
###end title 37
###begin p 38
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C10">10</xref>
###xml 430 434 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref>,<xref ref-type="bibr" rid="CVP037C10">10</xref></sup>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F4">4</xref>
###xml 611 620 611 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F4">4</xref>A</italic>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F4">4</xref>
###xml 746 755 746 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F4">4</xref>B</italic>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F4">4</xref>
###xml 887 896 887 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F4">4</xref>C</italic>
The increase in cTnI phosphorylation could result from either a sustained kinase activation or decreased phosphatase (particularly PP2A) activity. Hence, we undertook a series of experiments to investigate PP2A expression and activity in control and septic hearts. Since the vast majority of the C subunit resides in the cytosol and a relatively small percentage of this is translocated to the particulate fraction upon activation7,10 for most experiments, western blot analysis was performed on cytosolic and particulate fractions that were probed for cTnI and Rac-1, respectively, to ascertain fractionation (Figure 4A). In both cytosolic and particulate fractions, PP2A-C expression was significantly decreased in septic ventricles (P < 0.05; Figure 4B). In contrast, PP1 expression was not significantly altered in septic ventricles in either the cytosolic or particulate fractions (Figure 4C).
###end p 38
###begin p 39
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Representative blots showing fractionation of heart homogenate into cytosolic and particulate fractions using cardiac troponin I and Rac-1, respectively. (B) Representative blot and quantification of the amount of total protein phosphatase 2A (PP2A)-C in control and septic ventricular homogenates (n = 3 hearts/gp, *P < 0.05). (C) Representative blot and quantification of the amount of total PP1 in control and septic ventricular homogenates (n = 3 hearts/gp, P = ns). Band intensities are normalized to beta-actin as a loading control.
###end p 39
###begin title 40
Protein phosphatase 2A-B56alpha expression is significantly decreased in septic hearts
###end title 40
###begin p 41
###xml 411 412 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F5">5</xref>
###xml 404 413 394 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F5">5</xref>A</italic>
###xml 545 546 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F5">5</xref>
###xml 538 547 528 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F5">5</xref>A</italic>
###xml 725 726 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F5">5</xref>
###xml 718 727 708 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F5">5</xref>B</italic>
###xml 955 956 934 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F5">5</xref>
###xml 948 957 927 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F5">5</xref>C</italic>
The B subunit of PP2A is thought to contain the targeting information that directs the heterotrimer to specific cellular compartments. Hence, loss of the B56alpha subunit may prevent translocation of the catalytic unit to the required location. Western blot analysis demonstrated a dramatic reduction in the expression of the B56alpha subunit by 69 +/- 5% in septic myocytes in the particulate fraction (Figure 5A). A trend to a reduction in the cytosolic fraction was also observed, although this did not reach statistical significance (Figure 5A). To determine whether this reduction in protein levels was a result of a reduction at the mRNA level, we analysed mRNA expression in whole heart homogenate. As shown in Figure 5B, mRNA levels of B56alpha subunit showed a >50% reduction in septic hearts (LPS 0.046 +/- 0.008 vs. control 0.096 +/- 0.01 molar/molar ratio to beta-actin). No change in protein expression of PP2A-A subunit was observed (Figure 5C).
###end p 41
###begin p 42
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 195 196 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 213 214 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 294 295 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 395 396 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 413 414 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 425 426 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 529 530 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(A) Representative blot and quantification of the amount of the B56alpha subunit of protein phosphatase 2A (PP2A) in control and septic hearts separated into particulate and cytosolic fractions (n = 3 hearts/gp, *P < 0.001). Band intensities are normalized to beta-actin as a loading control. (B) Amount of mRNA of the B56alpha subunit present in control and septic hearts determined by RT-PCR (n = 3 hearts/gp, *P < 0.01). (C) Representative blot and quantification of the amount of PP2A-A subunit in septic and control hearts (n = 4 hearts/gp). Band intensities are normalized to beta-actin as a loading control.
###end p 42
###begin title 43
Methylation of the C subunit is decreased in septic hearts
###end title 43
###begin p 44
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 373 382 373 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>A</italic>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C18">18</xref>
###xml 873 875 873 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C18">18</xref></sup>
###xml 989 990 977 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 982 991 970 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>B</italic>
Post-translational methylation at Leu309 of the C subunit is thought to be an important mechanism for regulating the activity of PP2A. Methylation is thought to activate the enzyme and allow binding of the B subunit. We used an antibody specific for the demethylated (i.e. inactive) form of PP2A-C since there is no antibody available which recognizes the methylated form. Figure 6A demonstrates that there was a significant increase in the level of the demethylated form of PP2A-C in the particulate fraction of septic hearts. No changes were observed with CPA treatment, suggesting that CPA would not increase PP2A activity by increasing the methylation status of the catalytic subunit in septic hearts. No changes were observed in the cytosolic fractions (data not shown). Furthermore, the expression of the specific methyltransferase (PPMT) required to methylate PP2A-C18 was also shown to be significantly decreased in septic hearts (by approximately60% and 50%, respectively; Figure 6B).
###end p 44
###begin p 45
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 386 387 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 614 615 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 634 635 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 556 565 <span type="species:ncbi:64457">malachite</span>
(A) Representative blot and quantification of the amount of demethylated protein phosphatase 2A (PP2A)-C in the particulate fractions of control and septic hearts (n = 3 hearts/gp, *P < 0.01). (B) Representative blot and quantification of the amount of PPMT in control and septic hearts (n = 3 hearts/gp, *P < 0.01). Band intensities are normalized to beta-actin as a loading control. (C) Averaged data from three separate experiments of PP2A activity assay in septic and control hearts in the presence and absence of cyclopentyladenosine as determined by malachite green assay with absorbance measured at 612 nm (n = 4-7 hearts/gp, *P < 0.05).
###end p 45
###begin title 46
Cyclopentyladenosine treatment increases protein phosphatase 2A activity in septic hearts
###end title 46
###begin p 47
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 209 218 209 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>C</italic>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 306 315 306 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>C</italic>
In line with the significant reduction in protein expression of PP2A-B and -C subunits, a significant (P < 0.05) reduction in PP2A activity was also observed in septic heart homogenate compared with controls (Figure 6C). Treatment with CPA significantly increased PP2A activity in septic hearts (P < 0.05; Figure 6C). Taken in conjunction with the other data presented here, this finding strongly supports the hypothesis that a decrease in PP2A activity in sepsis results in increased cTnI phosphorylation and thus the pronounced contractile dysfunction observed in sepsis.
###end p 47
###begin title 48
Okadaic acid mimics the contractile dysfunction seen in septic hearts
###end title 48
###begin p 49
###xml 119 121 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C19">19</xref>
###xml 122 124 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C20">20</xref>
###xml 119 124 115 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C19">19</xref>,<xref ref-type="bibr" rid="CVP037C20">20</xref></sup>
###xml 341 342 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F7">7</xref>
###xml 334 342 330 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F7">7</xref></italic>
###xml 510 511 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F7">7</xref>
###xml 503 512 499 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F7">7</xref>A</italic>
###xml 548 549 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 549 552 545 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 765 766 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F7">7</xref>
###xml 758 767 750 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F7">7</xref>B</italic>
Okadaic acid is a protein phosphatase inhibitor that demonstrates selectivity for PP2A at concentrations <1 micromol/L.19,20 We reasoned that if the effects of sepsis are due in part to decreased PP2A activity, treatment of control myocytes with okadaic acid at doses specific for PP2A should mimic the contractile effects of sepsis. Figure 7 demonstrates that pre-treatment of control cardiomyocytes with okadaic acid (1 nmol/L) for 10 min reduced SS to almost exactly the same level as LPS treatment (Figure 7A). A similar effect was observed on Vmax (data not shown). In line with this, cTnI phosphorylation on Ser23/24 was increased by 248 +/- 52% following okadaic acid treatment, a level similar to the increase found in septic myocytes (301 +/- 59%) (Figure 7B).
###end p 49
###begin p 50
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
(A) Averaged contraction data for control, control + okadaic acid (OA) (1 nmol/L), and septic myocytes (n = 60-80 cells from three hearts; *P < 0.05); and (B) representative blot and quantification of Ser23/24 phosphorylation for control, control + OA (1 nmol/L), and septic myocytes. Band intensities are normalized to beta-actin as a loading control.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C4">4</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C5">5</xref>
###xml 220 223 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C4">4</xref>,<xref ref-type="bibr" rid="CVP037C5">5</xref></sup>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C6">6</xref>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C6">6</xref></sup>
Previous data from our laboratory have demonstrated that endotoxemia is associated with a sustained phosphorylation of cTnI at the PKA sites, serines 23/24, that results in a reduction in myofilament calcium sensitivity.4,5 Such an sustained increase in cTnI phosphorylation could result from either prolonged kinase activation or phosphatase inhibition. Pathways regulating the phosphorylation of cTnI at the PKA sites are relatively well understood;6 however, potential regulatory mechanisms controlling the dephosphorylation of cTnI remain unclear.
###end p 52
###begin p 53
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C21">21</xref>
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C21">21</xref></sup>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C22">22</xref>
###xml 107 109 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C22">22</xref></sup>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 366 367 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref></sup>
###xml 389 391 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C23">23</xref>
###xml 389 391 385 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C23">23</xref></sup>
###xml 457 458 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 457 458 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref></sup>
###xml 685 687 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C22">22</xref>
###xml 685 687 681 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C22">22</xref></sup>
###xml 849 851 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C24">24</xref>
###xml 849 851 841 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C24">24</xref></sup>
###xml 697 712 <span type="species:ncbi:10090">transgenic mice</span>
It was first suggested that PP2A was responsible for dephosphorylating cTnI by Mumby et al.21 Neuman et al.22 then described how inhibition of PP2A resulted in increased phosphorylation of contractile proteins such as cTnI and phospholamban without reducing cAMP levels. PP2A is thought to be the phosphatase mainly responsible for the dephosphorylation of both cTnI7 and alpha-tropomyosin23 in the sarcomere and phospholamban in the sarcoplasmic reticulum.7 PP2A has an important role in maintaining normal cardiac function, highlighted by the following observations: (i) inhibition of PP2A resulted in increased phosphorylation of cTnI and phospholamban without affecting cAMP levels22 and (ii) transgenic mice that over-expressed the catalytic PP2A Calpha in the heart developed cardiac hypertrophy, cardiac dilatation, and reduced contractility.24 The latter study also reported significant reduction in the phosphorylation of phospholamban, cTnI, and eukaryotic elongation factor 2.
###end p 53
###begin p 54
###xml 491 492 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
The major finding of the present study is that PP2A expression, regulation, and activity are significantly impaired in septic hearts. Also there is a significant reduction in the protein expression of PPMT which methylates PP2A and a concomitant increase in the level of demethylated (inactive) PP2A present in the septic hearts. This impairment in PP2A is associated with an increase in cTnI phosphorylation at Ser23/24 and a marked impairment of cardiac myocyte contractile function. The A1 adenosine agonist CPA significantly increased PP2A activity, reduced cTnI phosphorylation, and improved contractile function in septic myocytes.
###end p 54
###begin p 55
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C8">8</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C9">9</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C25">25</xref>
###xml 374 380 374 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C8">8</xref>,<xref ref-type="bibr" rid="CVP037C9">9</xref>,<xref ref-type="bibr" rid="CVP037C25">25</xref></sup>
###xml 542 549 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C26">26</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C28">28</xref>
###xml 550 555 550 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C26">26</xref>&#8211;<xref ref-type="bibr" rid="CVP037C28">28</xref></sup>
Protein phosphatase 2A is a serine/threonine phosphatase in which the catalytic (C) subunit is constitutively bound to the scaffolding (A) subunit. This heterodimer can then further complex with one of several regulatory B subunits, the identity of which is believed to determine the enzymatic activity, substrate specificity, and subcellular localization of the holoenzyme.8,9,25 Although PP2A is thought to exist predominantly as a trimer, there are several studies which suggest that the AC dimer and/or C alone may play significant roles in vivo.26-28
###end p 55
###begin p 56
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C29">29</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C30">30</xref>
###xml 380 385 380 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C29">29</xref>,<xref ref-type="bibr" rid="CVP037C30">30</xref></sup>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C31">31</xref>
###xml 424 426 424 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C31">31</xref></sup>
###xml 651 652 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 652 656 652 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP2A</sup>
###xml 662 663 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 663 670 663 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP2A,32</sup>
###xml 673 674 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 674 678 674 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP2A</sup>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C33">33</xref>
###xml 712 714 712 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C33">33</xref></sup>
###xml 724 725 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 725 729 725 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP2A</sup>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C34">34</xref>
###xml 760 762 760 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C34">34</xref></sup>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C35">35</xref>
###xml 879 881 879 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C35">35</xref></sup>
Regulation of PP2A activity is complex and mediated by several posttranslational modifications of both the B and C subunit. The C subunit can undergo posttranslational modifications such as carboxyl methylation of Leu309 at the C-terminus by a methyltransferase, and phosphorylation at Thr307 whereby methylation activates the enzyme and allows binding to the regulatory B subunit29,30 and phosphorylation inhibits activity.31 Methylation of the C unit is a highly conserved mechanism and therefore is thought to play a crucial role in PP2A regulation. Further regulation of PP2A activity is provided by two non-competitive inhibitor proteins termed I1PP2A and I2PP2A,32. I1PP2A is thought to be largely nuclear,33 whereas I2PP2A is diffuse within the cytosol.34 Both inhibitor proteins have acidic tails through which they may mediate their inhibitory effect on the phosphatase.35
###end p 56
###begin p 57
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C18">18</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C36">36</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C37">37</xref>
###xml 149 157 149 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C18">18</xref>,<xref ref-type="bibr" rid="CVP037C36">36</xref>,<xref ref-type="bibr" rid="CVP037C37">37</xref></sup>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C36">36</xref>
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C36">36</xref></sup>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C18">18</xref>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C18">18</xref></sup>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
Deregulation of PP2A is known to occur in Alzheimer's disease where an accumulation of phosphorylated tau proteins is a central pathological feature.18,36,37 Sontag et al.36 have demonstrated decreased expression levels of all the subunits of PP2A in the brains of Alzheimer's patients, in addition to changes in the carboxymethylation status of PP2A-C.18
###end p 57
###begin p 58
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C10">10</xref>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref>,<xref ref-type="bibr" rid="CVP037C10">10</xref></sup>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F4">4</xref>
###xml 379 388 379 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F4">4</xref>B</italic>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 427 436 427 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>A</italic>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 544 553 544 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures&#160;<xref ref-type="fig" rid="CVP037F2">2</xref></italic>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F3">3</xref>
###xml 558 559 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="CVP037F3">3</xref></italic>
Under basal conditions, the majority of PP2A-C resides in the cytoplasm and activation of the A1 receptor induces translocation to the particulate fraction.7,10 In the current study, we have demonstrated a significantly decreased expression of the catalytic subunit of PP2A in both the cytosolic and particulate fractions of septic hearts when compared with controls (P < 0.05) (Figure 4B). As such, activation of PP2A by CPA (Figure 6A) was associated with a marked decrease in cTnI phosphorylation and an improvement in contractile function (Figures 2 and 3). This is in line with the hypothesis that impaired PP2A activity and localization underlies the contractile dysfunction.
###end p 58
###begin p 59
###xml 467 469 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C36">36</xref>
###xml 467 469 451 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C36">36</xref></sup>
###xml 488 493 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 495 497 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C30">30</xref>
###xml 495 497 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C30">30</xref></sup>
###xml 643 645 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C30">30</xref>
###xml 643 645 623 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C30">30</xref></sup>
###xml 815 817 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C30">30</xref>
###xml 815 817 791 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C30">30</xref></sup>
As discussed above, the B subunits are thought to regulate the site of action of PP2A. Hence, the decrease in expression of the B56alpha subunit in the septic hearts, which is markedly clear in the particulate fraction, may provide one mechanism for the increased cTnI phosphorylation observed in these hearts. This decrease in protein expression was paralleled by a decrease in mRNA expression by approximately50% and again mirrors the results in Alzheimers disease.36 Similarly, Glaser et al.,30 in an established model of sustained JNK activation, reported a 70% decrease in expression of B56alpha in both neonatal and adult cardiomyocytes.30 A variety of other stress-related stimuli, such as p38 MAPK activation, phorbol esters, and LPS, also decreased B56alpha expression in this isolated myocyte preparation.30
###end p 59
###begin p 60
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C10">10</xref>
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C37">37</xref>
###xml 24 31 24 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref>,<xref ref-type="bibr" rid="CVP037C10">10</xref>,<xref ref-type="bibr" rid="CVP037C37">37</xref></sup>
###xml 325 327 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C29">29</xref>
###xml 325 327 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C29">29</xref></sup>
###xml 735 736 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 728 737 712 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>A</italic>
###xml 1065 1066 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C7">7</xref>
###xml 1065 1066 1049 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C7">7</xref></sup>
###xml 1258 1260 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C18">18</xref>
###xml 1261 1263 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C29">29</xref>
###xml 1258 1263 1242 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C18">18</xref>,<xref ref-type="bibr" rid="CVP037C29">29</xref></sup>
###xml 1546 1547 1530 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 1539 1548 1523 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>B</italic>
###xml 2151 2152 2131 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C9">9</xref>
###xml 2151 2152 2131 2132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C9">9</xref></sup>
###xml 2464 2465 2444 2445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F1">1</xref>
###xml 2456 2465 2436 2445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures&#160;<xref ref-type="fig" rid="CVP037F1">1</xref></italic>
###xml 2470 2471 2450 2451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 2470 2471 2450 2451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="CVP037F2">2</xref></italic>
###xml 2514 2515 2494 2495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F3">3</xref>
###xml 2507 2516 2487 2496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F3">3</xref>B</italic>
###xml 2559 2560 2539 2540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F6">6</xref>
###xml 2552 2561 2532 2541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F6">6</xref>C</italic>
###xml 2791 2792 2771 2772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F7">7</xref>
###xml 2784 2792 2764 2772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F7">7</xref></italic>
Although several authors7,10,37 have demonstrated that CPA can induce translocation of PP2A-C to the membrane fraction, the mechanisms that regulate this process are far from clear. As discussed above, alpha-carboxyl methyl esterification of the C subunit has been reported to regulate PP2A by modulating holoenzyme assembly.29 Therefore, we hypothesized that decreased methylation would correlate with a decreased association with the B subunit, decreased activity, and possibly changes in localization. Using an antibody that specifically recognizes the demethylated form of PP2A-C, we demonstrated a significant increase (approximately35-fold) in the demethylated form of PP2A-C in the particulate fraction of septic hearts (Figure 6A). Given that the overall expression of PP2A-C is significantly decreased, this represents a large decrease in the amount of the methylated form. However, we could not demonstrate a reduction in demethylated PP2A-C following CPA treatment in either control or septic hearts. This is in contrast to the results of Liu and Hofmann7 who demonstrated a decrease in the level of demethylated PP2A-C following a 5 min of incubation with CPA. Methylation of PP2A-C is catalysed by a specific Leu carboxyl methyltransferase PPMT.18,29 Hence, we examined the protein expression of PPMT in the cytosolic and particulate fractions of control and septic hearts. In line with the increase in demethylated PP2A-C (reflecting a decreased methylation), the amount of PPMT was significantly decreased in septic hearts (Figure 6B). Thus, the increased cTnI phosphorylation observed in septic hearts could reflect a decreased PP2A-C methylation as a result of a significant decrease in the methyltransferase that methylates this subunit. The consequence of this would be a decreased association of the B subunit with the A/C heterodimer, an association required for targeting and activation of the holoenzyme. Furthermore, the decreased expression of B56alpha at both protein and mRNA level may reflect a failure to associate with the catalytic subunit since only the heterotrimeric forms of PP2A appear to be stable in intact cells.9 Additional support for a role for PP2A in the modulation of contractile function via dephosphorylation of cTnI is provided by the demonstration that septic hearts have significantly lower PP2A activity compared with control cells. Furthermore, treatment with CPA not only improved contractile function (Figures 1 and 2) and reduced cTnI phosphorylation (Figure 3B) but also increased PP2A activity (Figure 6C). Also, incubation of control cells with okadaic acid, at a concentration that specifically inhibits PP2A, mimicked the effects of sepsis in terms of both decreased contractile function and increased cTnI phosphorylation (Figure 7).
###end p 60
###begin p 61
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="CVP037F2">2</xref>
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure&#160;<xref ref-type="fig" rid="CVP037F2">2</xref></italic>
###xml 298 300 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 409 411 409 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 702 703 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 723 724 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 739 744 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 745 747 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C38">38</xref>
###xml 745 747 742 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C38">38</xref></sup>
###xml 791 792 788 789 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 829 830 823 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 931 936 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 937 939 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C39">39</xref>
###xml 937 939 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C39">39</xref></sup>
###xml 1054 1055 1045 1046 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1322 1323 1310 1311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1500 1502 1488 1490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1540 1541 1528 1529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1569 1571 1557 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CVP037C40">40</xref>
###xml 1569 1571 1557 1559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="CVP037C40">40</xref></sup>
###xml 1595 1596 1583 1584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1781 1782 1766 1767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1851 1852 1836 1837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1988 1990 1969 1971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 2152 2153 2133 2134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 2175 2176 2156 2157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2233 2234 2211 2212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2245 2246 2223 2224 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1078 1088 <span type="species:ncbi:10141">guinea-pig</span>
###xml 1438 1442 <span type="species:ncbi:10116">rats</span>
Treatment of septic cardiomyocytes with the PKA inhibitor H89 improved contractile function to a similar extent to CPA treatment (Figure 2), while the combination of CPA and H89 further improved contractile function to baseline levels. Both of these treatments were independent of changes in the Ca2+ transient, suggesting that the improvement in contractile function reflected a restoration in myofilament Ca2+ sensitivity. The mechanism underlying the beneficial effect of H89 requires further investigation. While it is likely that H89 is acting by directly inhibiting PKA-mediated phosphorylation of cTnI, it is also possible that the mechanism involves dephosphorylation and uncoupling of the beta2-adrenoceptor from Gi. Hence, Daaka et al.38 demonstrated that stimulation of MAPK via Gi requires phosphorylation of the beta2-receptor by PKA and that H89 inhibited isoprenaline-mediated activation of MAPK. Similarly, Faucher et al.39 recently demonstrated that PKA activation was a prerequisite for the negative inotropic effect induced by the beta2-agonist salbutamol in guinea-pig papillary muscles. As such, H89 significantly reduced the negative inotropic effect induced by salbutamol. Furthermore, okadaic acid (at a dose that would inhibit both PP1 and PP2A) significantly increased the sensitivity of the beta2-adrenoceptor to salbutamol suggesting phosphatases modulate the response. Lastly, in adult myocytes isolated from rats injected with LPS, the decrease in cell shortening and Ca2+-transients could be reversed by the Gi inhibitor, pertussis toxin,40 again suggesting that Gi protein signalling plays a role in the negative inotropic effect of LPS. In the light of these studies, the results of the current study suggest that in septic cardiomyocytes, the beta2-adrenoceptor is phosphorylated thereby switching the signalling to Gi. Importantly, use of a specific cGMP-dependent protein kinase inhibitor (Rp-8-Br-cGMPs; 10 microM) had no effect on either SS or the Ca2+ transient in control or septic cardiomyocytes (data not shown). This excludes a non-specific effect of H89 on PKG. However, such a mechanism would require that Gi signalling from the A1-receptor activates different signalling pathways to beta2-mediated Gi signalling if the beneficial effects of CPA and H89 are to be reconciled. Further studies will be required to explore this protective effect.
###end p 61
###begin p 62
###xml 184 188 <span type="species:ncbi:10090">mice</span>
In conclusion, the studies presented here strongly support the hypothesis that the increased cTnI phosphorylation and reduced contractility apparent in cardiomyocytes from LPS-treated mice results, at least in part, from an inhibition of PP2A activity. This reduction in PP2A activity may reflect a decrease in PPMT expression resulting in decreased PP2A-C methylation, an inability to assemble the holoenzyme and thus increased cTnI phosphorylation. The inability to form the holoenzyme may underlie the reduction in expression of the B56alpha and C subunits in septic hearts.
###end p 62
###begin p 63
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest:</bold>
Conflict of interest: none declared.
###end p 63
###begin title 64
Funding
###end title 64
###begin p 65
###xml 30 68 30 68 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">British Heart Foundation (BHF) Project</grant-sponsor>
###xml 68 85 68 85 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grant (PG/03/107)</grant-num>
###xml 90 99 90 99 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHF award</grant-sponsor>
###xml 101 109 101 109 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CH/99001</grant-num>
This study was supported by a British Heart Foundation (BHF) ProjectGrant (PG/03/107) and BHF award (CH/99001). Funding to pay the Open Access charge was provided by the BHF.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides
###end article-title 67
###begin article-title 68
Pathogenic mechanisms of septic shock
###end article-title 68
###begin article-title 69
Cardiac dysfunction in sepsis: new theories and clinical implications
###end article-title 69
###begin article-title 70
###xml 102 106 <span type="species:ncbi:10116">rats</span>
Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats
###end article-title 70
###begin article-title 71
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I
###end article-title 71
###begin article-title 72
Regulation of cardiac contractile function by troponin I phosphorylation
###end article-title 72
###begin article-title 73
Antiadrenergic effects of adenosine A1 receptor-mediated protein phosphatase 2a activation in the heart
###end article-title 73
###begin article-title 74
Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55
###end article-title 74
###begin article-title 75
Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits
###end article-title 75
###begin article-title 76
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
A novel role for protein phosphatase 2A in receptor-mediated regulation of the cardiac sarcolemmal Na+/H+ exchanger NHE1
###end article-title 76
###begin article-title 77
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Modulation of protein phosphatase 2A by adenosine A1 receptors in cardiomyocytes: role for p38 MAPK
###end article-title 77
###begin article-title 78
###xml 23 24 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration
###end article-title 78
###begin article-title 79
A novel cAMP-stimulated pathway in protein phosphatase 2A activation
###end article-title 79
###begin article-title 80
Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes
###end article-title 80
###begin article-title 81
Antapoptotic activity of AKT is down-regulated by Ca2+ in myocardial H9c2 cells
###end article-title 81
###begin article-title 82
###xml 101 104 <span type="species:ncbi:10116">rat</span>
Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes
###end article-title 82
###begin article-title 83
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically
###end article-title 83
###begin article-title 84
Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis
###end article-title 84
###begin article-title 85
Protein phosphatases regulate DNA-dependent protein kinase activity
###end article-title 85
###begin article-title 86
Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2A
###end article-title 86
###begin article-title 87
Cardiac contractile protein phosphatases
###end article-title 87
###begin article-title 88
Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin
###end article-title 88
###begin article-title 89
P38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity
###end article-title 89
###begin article-title 90
Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function
###end article-title 90
###begin article-title 91
Methylation of the C-terminal leucine residue of the PP2A catalytic subunit is unnecessary for the catalytic activity and the binding of regulatory subunit (PR55/B)
###end article-title 91
###begin article-title 92
Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: Abundant expression of both forms in cells
###end article-title 92
###begin article-title 93
B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A
###end article-title 93
###begin article-title 94
Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favours association with the alpha4 subunit which promotes dephosphorylation of elongation factor-2
###end article-title 94
###begin article-title 95
Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits
###end article-title 95
###begin article-title 96
JNK activation decreases PP2A regulatory subunit B56alpha expression and mRNA stability and increases AUF1 expression in cardiomyocytes
###end article-title 96
###begin article-title 97
Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts
###end article-title 97
###begin article-title 98
###xml 110 116 <span type="species:ncbi:9913">bovine</span>
Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney
###end article-title 98
###begin article-title 99
Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements
###end article-title 99
###begin article-title 100
Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII
###end article-title 100
###begin article-title 101
Molecular identification of I, a novel potent heat-stable inhibitor protein of protein phosphatase 2A
###end article-title 101
###begin article-title 102
Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology
###end article-title 102
###begin article-title 103
###xml 122 125 <span type="species:ncbi:10116">rat</span>
p38 mitogen-activated protein kinase contributes to adenosine A1 receptor-mediated synaptic depression in area CA1 of the rat hippocampus
###end article-title 103
###begin article-title 104
Switching of the coupling of the [beta]2-adrenergic receptor to different G proteins by protein kinase A
###end article-title 104
###begin article-title 105
###xml 110 120 <span type="species:ncbi:10141">guinea pig</span>
Roles of PKA, PI3K and cPLA2 in the NO-mediated negative inotropic effect of {beta}2-adrenoceptor agonists in guinea pig right papillary muscles
###end article-title 105
###begin article-title 106
###xml 46 49 <span type="species:ncbi:10116">rat</span>
Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes
###end article-title 106

